Jason Kolbert

Stock Analyst at D. Boral Capital

(0)
# 4537
Out of 5,218 analysts
189
Total ratings
25.79%
Success rate
-13.41%
Average return
64 Stocks
Name Action Price Target Current % Upside Ratings Updated
CARISMA Therapeutics
Maintains: Buy
12 12
0.4 2900% 6 Dec 12, 2024
Trevi Therapeutics
Maintains: Buy
21 21
4.17 403.6% 7 Dec 12, 2024
Enlivex Therapeutics
Maintains: Buy
13 13
1.18 1001.69% 6 Dec 11, 2024
CervoMed
Downgrades: Hold
n/a
n/a n/a 3 Dec 10, 2024
Imunon
Maintains: Buy
29 29
0.84 3352.38% 5 Dec 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5 5
0.57 777.19% 3 Dec 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
23 23
4.8 379.17% 6 Dec 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
128 128
5.64 2169.5% 5 Dec 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
6 6
1.11 440.54% 2 Dec 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
25 25
11.35 120.26% 6 Dec 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
9 9
2.11 326.54% 2 Dec 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10 10
1.58 532.91% 5 Dec 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
15
5.76 160.42% 1 Dec 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
14 14
3.74 274.33% 3 Nov 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
46 46
8.41 446.97% 5 Nov 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
9
1.39 547.48% 1 Nov 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 6 Nov 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
30 30
2.85 952.63% 4 Nov 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
25 25
4.08 512.75% 5 Nov 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
9 9
0.55 1536.36% 3 Nov 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
3 2
0.5 300% 2 Nov 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
16 16
2.19 630.59% 5 Nov 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10 10
2.84 252.11% 6 Nov 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
18 18
2.35 665.96% 7 Nov 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
31 31
1.2 2483.33% 3 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
12 12
2.03 491.13% 3 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
15 15
2.62 472.52% 3 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
9 9
1.81 397.24% 2 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
3 3
0.26 1053.85% 5 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5 5
0.81 517.28% 3 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10 10
1.06 843.4% 7 Nov 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
21 21
5.26 299.24% 4 Nov 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
17 17
1.13 1404.42% 4 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
21 21
n/a n/a 3 Oct 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
16
4.34 268.66% 1 Sep 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
6 6
1.08 455.56% 1 Aug 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
96
0.24 39900% 1 Feb 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Aug 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Jul 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
16002 45990
3.38 1360550.89% 1 Feb 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
120
1.14 10426.32% 1 Jan 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
0.12 4900% 1 Jan 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Sep 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25200
0.01 251999900% 1 Aug 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Jul 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 May 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
7
n/a n/a 1 Feb 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
60
n/a n/a 1 Jan 31, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Oct 13, 2021